Thermo Fisher Scientific Inc.’s Stock Price Skyrockets to $606.74, Marking a Robust 6.78% Uptick

Thermo Fisher Scientific Inc. (TMO)

606.74 USD +38.51 (+6.78%) Volume: 3.34M

Thermo Fisher Scientific Inc.’s stock price is currently standing strong at 606.74 USD, demonstrating a remarkable trading session with an increase of +6.78%. With a trading volume of 3.34M and an impressive year-to-date percentage change of +16.63%, TMO’s stock performance continues to attract investors.

Latest developments on Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (TMO) is experiencing significant stock price movements today as negotiations are underway regarding the potential relocation of its operations. The company recently reported a strong earnings beat, with profit and revenue rising in the fourth quarter of 2024. Thermo Fisher’s new products have been driving growth, leading to robust profit expectations for 2025. Despite facing headwinds, the company’s stock surged after surpassing earnings estimates and seeing increased demand for its tools and services. Investors are closely watching Thermo Fisher’s performance, making it a top stock to consider for beginners in 2025.

Thermo Fisher Scientific Inc. on Smartkarma

Analysts on Smartkarma, like Baptista Research, have published research on Thermo Fisher Scientific Inc. In their report titled “Thermo Fisher Scientific: Expansion of Clinical Research & Pharma Services Integration Driving Our Bullishness! – Major Drivers,” they highlight the company’s strong third-quarter performance in 2024. Thermo Fisher Scientific reported quarterly revenue of $10.6 billion and an adjusted operating income of $2.36 billion, with an adjusted operating margin of 22.3%. The company’s adjusted earnings per share (EPS) was $5.28, showcasing their ability to consistently create value for shareholders.

A look at Thermo Fisher Scientific Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Thermo Fisher Scientific Inc, a company that manufactures scientific instruments and chemicals, has received a mixed outlook based on Smartkarma Smart Scores. While the company scores well in terms of momentum, indicating positive market sentiment, it falls short in areas such as dividend and resilience. With an overall outlook that leans towards the positive side, investors may want to consider the company’s growth potential and value proposition in the long term.

Thermo Fisher Scientific Inc‘s Smartkarma Smart Scores reveal a company with strong momentum but room for improvement in areas like dividend and resilience. Despite these challenges, the company’s focus on growth and value could position it well for the future. As a manufacturer of scientific instruments and consumables, Thermo Fisher Scientific Inc serves a variety of industries, including pharmaceutical companies, research institutions, and government agencies, highlighting its diverse customer base and potential for long-term success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma